Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +0.46%42 5-Year ROIIC % is 31.35 as of Mar. 2026. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 106 Medical Distribution companies, Amwill Health Care ranks better than 85.85% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Amwill Health Care's 5-Year ROIIC % for the quarter that ended in Mar. 2026 was 31.35%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Amwill Health Care's 5-Year ROIIC % or its related term are showing as below:
BOM:544353's 5-Year ROIIC % is ranked better than 85.85% of 106
companies
in the Medical Distribution industry
Industry Median: 3.025
vs BOM:544353: 31.35
Amwill Health Care (BOM:544353) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Amwill Health Care 5-Year ROIIC % Related Terms
Amwill Health Care 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544353 vs MCK, COR, CAH: 5-Year ROIIC % Comparison
For the Medical Distribution subindustry, Amwill Health Care's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care 5-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Amwill Health Care (BOM:544353) has a 5-Year ROIIC % of 31.35 as of Mar. 2026. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Amwill Health Care and its competitors. According to the industry distribution chart, Amwill Health Care ranks #15 out of 106 companies in the Medical Distribution industry, placing it in the top 14.2%.
Is Amwill Health Care's 5-Year ROIIC % too high?
Amwill Health Care's current 5-Year ROIIC % is 31.35. The Medical Distribution industry median 5-Year ROIIC % is 3.03. Amwill Health Care's value of 31.35 is 936.4% above this industry median. Based on the distribution chart, Amwill Health Care ranks #15 out of 106 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's 5-Year ROIIC % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #15 out of 106 companies for 5-Year ROIIC %. This places Amwill Health Care in the top 14% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 3.03. Amwill Health Care's value of 31.35 is 936.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Distribution company?
The median 5-Year ROIIC % among Medical Distribution companies is 3.03, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amwill Health Care's current 5-Year ROIIC % of 31.35 is 936.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median 5-Year ROIIC % is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current 5-Year ROIIC % is 31.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current 5-Year ROIIC % of 31.35. The current 5-Year ROIIC % is 31.35 and 936.4% above the Medical Distribution industry median of 3.03. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current 5-Year ROIIC % is 31.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
